Skip to main content
lexblog.com/lib/Q36CGTW2viewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "FDA Clarifies Labeling Expectations for Prescription Drug Use-Related Software",
    "url": "https://www.lexblog.com/2023/09/26/fda-clarifies-labeling-expectations-for-prescription-drug-use-related-software/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-Q36CGTW2",
        "url": "https://www.lexblog.com/lib/Q36CGTW2/"
    },
    "datePublished": "2023-09-26T18:47:12-04:00",
    "dateModified": "2023-09-26T15:47:56-04:00",
    "author": {
        "@type": "Person",
        "name": "Dominick DiSabatino, Audrey Mercer"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Sheppard, Mullin, Richter & Hampton LLP"
    },
    "organizationScope": "at-publication",
    "about": "Food, Drug & Agriculture",
    "sourceUrl": "https://www.fdalawblog.com/?p=2113",
    "sourceStability": "may-move"
}